Monday, March 27, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Preparedness

How Candida albicans Exploits Lack of Oxygen to Cause Disease

Umeå University scientists show how Candida albicans adapts to low oxygen levels to cause infection.

by Global Biodefense Staff
January 30, 2019
How Candida albicans Exploits Lack of Oxygen to Cause Disease

An electron micrograph of neutrophils interacting with a fungal biofilm in an anoxic environment. Neutrophils are not able to respond with their full antifungal potential. The image was acquired at the Umeå Core Facility for Electron Microscopy. Credit: Umeå Core Facility for Electron Microscopy (UCEM)

Researchers from Umeå University have shown how adaption of microbial fungi to low oxygen environments influences their recognition by immune cells and their ability to thrive and cause harmful infection within the host.

The research was published recently in the journal mBio, a publication of the American Society of Microbiology.

“It was very surprising to see that the fungus does not require oxygen to cause disease. Unexpectedly, the microbial pathogen could even use low oxygen environments to evade immune attack and to become more virulent.” – says Constantin Urban, Associated Professor at the Department of Clinical Microbiology.

Interestingly, C. albicans is a commensal microbe of our gastrointestinal system and when natural barriers fail, due to immunosuppressive disease or treatment, C. albicans can spread from its natural reservoir and invade the body to cause life-threatening, systemic disease. “We now understand how C. albicans under these circumstances exploits the training from anoxic commensal niches to thrive in deep-seeded body sites which quickly induce inflammation and immune cell recruitment. Both processes rapidly exhaust oxygen and in turn create low oxygen milieus.” – continues Dr. Urban.

Candida albicans is the most common fungal pathogen and a common cause of sepsis. While most individuals are infected with Candida albicans since birth, the infection causes serious illness or even death, particularly among those with a weakened immune system. Their new study is a step towards the characterization of immune responses under low oxygen levels, a frequent stress condition during inflammation and infection. Particularly neutrophils, the most abundant white blood cell and essential defence line against fungal microbes, where hampered in their ability to attack and eradicate C. albicans under low oxygen conditions, whereas the neutrophils’ metabolism and viability seemed unaffected.

The research may be applied to future therapy strategies to reduce premature deaths and to improve patients’ life quality.

Tags: Candida albicansFungal InfectionsInfection Prevention + ControlSepsis

Related Posts

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA
Funding News

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Predictive Intelligence for Pandemic Prevention Grant Awarded to Virginia Tech Researchers
Preparedness

Predictive Intelligence for Pandemic Prevention Grant Awarded to Virginia Tech Researchers

October 25, 2022
dressed head to toe in protective suit and gloves, a worker places a dropper of liquid onto a small plastic device to test for Ebola virus
Outbreak News

How Prepared is Uganda for the Current Ebola Outbreak?

September 24, 2022
A Treaty to Break the Pandemic Cycle: Don’t Ignore Key Lessons from the Past Two Years
Policy + Initiatives

A Treaty to Break the Pandemic Cycle: Don’t Ignore Key Lessons from the Past Two Years

July 16, 2022
Load More

Latest News

Biodefense Headlines – 26 March 2023

March 26, 2023
Biodefense Headlines – 12 March 2023

Biodefense Headlines – 12 March 2023

March 12, 2023
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC